Article info
PDFNeurodegeneration
Original research
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease
- Correspondence to Professor Markus Otto, Department of Neurology, University Hospital Ulm, 89069 Ulm, Baden-Württemberg, Germany; markus.otto{at}uni-ulm.de
Citation
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease
Publication history
- Received June 18, 2020
- Revised September 30, 2020
- Accepted November 24, 2020
- First published December 30, 2020.
Online issue publication
March 12, 2021
Article Versions
- Previous version (30 December 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.